Document:

CONSULTING AGREEMENT

THIS CONSULTING AGREEMENT (the "Agreement") is entered into on January 12, 2005,
by and between CALYPSO WIRELESS, INC., a Delaware corporation having it's
principal offices at 5753 NW 158 Street, Miami Lakes, FL. 33014 ("Calypso" or
"Company"), and Bierman, Shohat, Loewy & Pizzi, P.A. a Florida corporation
having its principal offices at 800 Brickel Avenue, Miami, Florida
(Consultant").

                                    RECITALS

         A. Calypso is in the process of suing Luis Armelino, Gabriel Marquinez,
Luis de Garcia and Ruben Garza in Case Number 03-04342 in Miami Dade Circuit
Court to recoup and return to the Company 10 million (10,000,000) shares of
stock that was fraudulently stolen, and desires to retain the services of
Consultant to assist Calypso in prosecuting claim related to Case number
03-04342.

         B. Consultant represents to Calypso that he has the expertise and
experience to render the consulting services related to the business of Calypso.

                                    AGREEMENT

         Therefore, in consideration of the mutual promises, covenants and
conditions set forth herein, and for other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, the parties agree as
follows:

1.       Consulting Services. During the term of this Agreement, Consultant
shall provide Company with the following consulting services (the "Services"):

         (a)      Assist Company in connection with pursuing and preserving a
                  final judgment recouping the shares of stock that were stolen
                  from Calypso, Inc, including handling all litigation involved
                  in Miami Dade Circuit Court case number 03-4342.

         (b)      Consultant shall not negotiate or enter into any contract,
                  agreement or understanding with any third-parties on behalf of
                  Company without Company's knowledge or consent. Consultant
                  shall not be required to perform a minimum number of hours of
                  services under this Agreement, yet Consultant shall provide
                  her/his good faith best efforts to provide the requisite time
                  and effort to help Company. Calypso recognizes and agrees that
                  Consultant is engaged in several business activities
                  independent of the Services.

2.       Consulting Fee

         In consideration of the Services to be rendered by Consultant as agreed
         between Consultant and Calypso on "Contract of Employment" signed on
         January, 12, 2005, Calypso shall remunerate Consultant by granting
         Consultant Four Hundred and Twenty Five Thousand Shares (425,000) free
         trading S-8 shares of Calypso Wireless, Inc., common stock (the "Common
         Stock"), subject to the terms and conditions of this Agreement. The
         shares will be forwarded to Consultant as requested from Consultant on
         one certificate as follows: (425,000) shares to Michael A. Pizzi, Jr.
         due and payable immediately.

3.       Securities Representations. Consultant hereby represents that:

         3.1   Consultant is an "Accredited Investor," as such term is defined
under Rule 501 of Regulation D of the Securities Act of 1933, as amended;
<PAGE>

         3.2   Consultant has discussed with Company's management the business
plans for the Company;

         3.3   Consultant has had the opportunity to question the principals of
Company as to all matters which he deems material and relevant to his decision,
if applicable, to purchase the Company's Common Stock, and has had the
opportunity to obtain any and all additional information necessary to verify the
accuracy of the information received or any other supplemental information which
he deems relevant to make an informed investment decision; and

         3.4   Consultant understands the risks of an investment in the
Company's Common Stock, and has consulted with an attorney and/or accountant to
the extent he deemed it necessary in reviewing his acquisition of the Company's
Common Stock.

4.       Representations and Warranties of Consultant. In connection with this
Consulting Agreement, Consultant hereby represents, warrants and confirms the
following understandings to the Corporation as follows:

         4.1   Review and Evaluation of Information. Consultant (i) has been
provided with information b. concerning the formation and organization of
Company and the development of its business prospects to date, (ii) has had the
opportunity to inspect the assets of the Company and its business, corporate and
financial records, (iii) has had the opportunity to ask the Company's officers
and directors questions about the Company's business, operations, financial
records and proposed operations as well as the Company's current growth and
market strategy, (iv) has had the opportunity to review and evaluate all
information provided by the Company's business development and acquisition
prospects, (v) has had the opportunity to interview and independently evaluate
the management and operations personnel of the Company, and (vi) has had the
opportunity to obtain, and has obtained, all information required to form an
informed independent evaluation of the likelihood of the success or failure of
the Company and its proposed new business initiatives. Consultant has also had
the opportunity to ask questions about the Consulting Agreement and has obtained
such additional information as requested to the extent deemed necessary to
permit full evaluation of the merits and risks of an investment in the Shares.
In addition, Consultant has consulted with its investment, accounting, legal and
tax advisors as it deemed necessary and appropriate in making his decision to
acquire the Shares.

         4.2   Forward-Looking Information. Consultant understands and agrees
that all statements contained in the business plans for the Company's new
business initiatives, other than statements of historical fact, such as
statements regarding the Company's financial projections, estimated future
revenues, net income, business strategy and plans and objectives for future
operations, are Aforward-looking statements@. These forward-looking statements
are commonly identified by the use of phrases as Aintends,@ Aestimates,@
Aexpects,@ Aprojects,@ Aanticipates,@ Aforeseeable future,@ Aseeks,@ Abelieves,@
and Ascheduled@. The Company's financial projections were based upon assumptions
which the Company and/or its vendors believe to be reasonable but which have not
been reviewed by any independent professional on behalf of the Company.
Consultant acknowledges and agrees that there can be no assurance that such
assumptions will be correct and that actual results will not be materially
different from those set forth in the business plans for its new business
initiatives.

         4.3   Consultant 's Financial Experience. Consultant is sufficiently
experienced in financial and business matters to be capable of evaluating the
merits and risks of his investment in the Shares.

         4.4   Independent Evaluation. Consultant acknowledges that its
investment is being made based upon his independent analysis, together with
assistance from his investment, accounting, legal and tax advisors as he deemed
necessary and appropriate in making an investment decision with respect to the
Shares, and that Consultant and its advisors are not relying upon any statement,
opinion, conclusion, projection or other analysis of the Company or any Company
representative.

                                       2
<PAGE>

         4.5   Suitability of Investment. Consultant has been advised that the
Company has a limited operating history and that its new business initiatives
are undeveloped, and there can be no assurance that the Company will ever be
profitable. Consultant has evaluated the merits and risks of Consultant's
proposed acquisition of the Shares, including those risks particular to
Consultant's circumstances, and has determined that the investment is suitable
for Consultant. Consultant has adequate financial resources for an investment of
this character, and could bear a complete loss of his investment. Further,
Consultant will continue to have, after making his investment in the Company,
adequate means of providing for its current operations, the needs of those
dependent on Consultant, and its possible contingencies.

         4.6   Unregistered Offering. Consultant and its Consultant
Representative, if any, understands that the Shares not being registered under
the Act because the sale is exempt from registration under the Securities Act,
and rules and regulations promulgated there under, as a "transaction by an
issuer not involving any public offering," and pursuant to certain other
exemptions, and that the availability of such exemptions is predicated, in part,
on Consultant's representations and warranties contained in this Consulting
Agreement. In the view of the Securities and Exchange Commission, the statutory
basis for the exemption claimed by the Company in connection with the sale of
Shares would not be present if, notwithstanding Consultant's representations and
warranties, Consultant has the intention of acquiring any such securities for
resale upon the occurrence or nonoccurrence of some predetermined event.

         4.7   Limited Market for the Shares. Consultant understands that there
is a limited public market for the Shares, and that, as a result, an investment
in the Company's Common Stock may be highly illiquid. Consultant may not be able
to sell its Shares readily or at all when it needs or desires to sell. Trading
in the Company's Common Stock has recently been reported in the National
Quotation Bureau's Pink Sheets. Consultant has been advised, however, that a
public trading market having the characteristics of depth, liquidity and
orderliness depends upon the existence of market makers as well as the presence
of willing buyers and sellers, which are circumstances over which the Company
does not have control. There can be no assurance that the market will provide
significant liquidity for Consultant's sale of the Shares. Consultant can afford
to hold the Shares for an indefinite period of time.

         4.8   Absence of Official Evaluation. Consultant understands that no
federal or state agency has made any finding or determination as to the fairness
of the terms of an investment in the Company, nor any recommendation or
endorsement of an acquisition of the Shares.

         4.9   Residency. Consultant's residence or principal place of business,
as applicable, is the country and state or other jurisdiction indicated below,
and Consultant's citizenship or jurisdiction of incorporation, as applicable, is
as indicated opposite his or its signature to this Consulting Agreement.
Consultant has no intent of changing his residency, citizenship, or principal
office to any other country or state or jurisdiction.

         4.10  Consultant Information. Consultant understands that acceptance of
his Consulting Agreement is based, in part, on the information provided by
Consultant to the Company. Consultant represents that the information provided
by Consultant is true, correct, and complete at the date hereof, and Consultant
agrees to notify the Company immediately of any change in such information.
Consultant understands that the information furnished is intended to enable the
Company to discharge its responsibilities and that the Company will rely upon
such information.

Consultant understands and agrees that, although the Company will use its best
efforts to keep the information provided by purchaser strictly confidential, it
may present the information provided to it to such parties as it may deem
advisable if called upon to establish the availability under any federal or
state securities laws, or if the contents hereof are relevant to any issue in
any action, suit or proceeding to which the Company is a party, or by which the
Company is or may be bound.

                                       3
<PAGE>

         4.11 Nonreliance. Consultant is not relying on the Company or any legal
opinion with respect to the tax and economic effect of his investment in the
Company.

         4.12 Prohibitions on Cancellation, Termination, Revocation,
Transferability, and Assignment. Consultant hereby acknowledges and agrees that,
except as may be specifically provided herein or by applicable law, it is not
entitled to cancel, terminate, or revoke this Consulting Agreement, and this
Consulting Agreement shall survive the death, dissolution or other termination
of Consultant, as applicable, and any transfer of the Shares.

         4.13 Indemnification of The Company and The Seller. Consultant agrees
to indemnify and hold harmless the Company against any and all loss, liability,
claim, damage, and expense whatsoever (including, but not limited to, any and
all expenses whatsoever, including attorneys' fees, reasonably incurred in
investigating, preparing, or defending against any litigation commenced or
threatened or any claim whatsoever through all appeals) arising out of or based
upon any false representation or warranty or breach or failure by Consultant to
comply with any covenant or agreement made by Consultant herein or in any other
document furnished by Consultant in connection with this Consulting Agreement.

         4.14 State Securities Laws. Consultant received this Agreement and
first learned of the Consulting Agreement offer hereby in Miami. Consultant
executed and will execute all documents contemplated hereby in Miami, and
intends that the laws of Florida govern this Consulting Agreement.

         4.15 Authority. Consultant has the capacity, power and authority to
execute this Consulting Agreement and perform it obligations hereunder. This
Agreement has been duly executed and delivered by Consultant and (assuming the
due execution and delivery hereof by the Corporation) constitutes a valid and
binding obligation of Consultant enforceable against Consultant in accordance
with its terms.

5.       Representations of the Corporation. The Corporation hereby represents
and warrants to Consultant that, upon the services rendered the Corporation will
issuance and delivery the Stock to Consultant in accordance with the terms and
conditions of this Agreement, the Stock will be duly authorized, validly issued,
fully paid and nonassessable; and Consultant will be the true and lawful owner
of the Stock, and will hold such Stock free and clear of any and all security
interests, liens, claims, options, charges or other legal or equitable
restrictions.

7.       Term. The term of this Agreement (the "Initial Term") shall commence
(the "Commencement Date") on the date the "Contract of Employment" was executed
on January 12, 2005.

8.       Certain Restrictive Covenants: Confidentiality; Noncompetition; Non
Solicitation.

         8.1. Confidentiality. Consultant recognizes, acknowledges and agrees
with Company that he will not at any time, except in performance of her
obligations to Company hereunder or with the prior written consent of Company,
directly or indirectly, reveal to any person, entity or other organization
(other than Company, or its employees, officers, directors, shareholders or
agents) or use for her own benefit any information deemed to be confidential by
Company or any of its subsidiaries or affiliates (such subsidiaries and
affiliates, collectively "Affiliates") ("Proprietary Information") relating to
the assets, liabilities, employees, goodwill, business or affairs of Company or
any of its Affiliates including, without limitation, any information concerning
past, present or prospective customers, technology, commercial and strategic
relationships, marketing data, or other Proprietary Information used by, or
useful to, Company or any of its Affiliates and known (whether or not known with
the knowledge and permission of Company or any of its Affiliates and whether or
not at any time prior to the date of this Agreement developed, devised, or
otherwise created in whole or in part by the efforts of Consultant) to
Consultant by reason of performance of the Services, shareholdings in or other
association with Company or any of its Affiliates. Consultant further agrees
that he will retain all copies and extracts of any written Proprietary
Information acquired or developed by her during any such service, shareholding
or association in trust for the sole benefit of Company, its Affiliates and

                                       4
<PAGE>

their successors and assigns. Consultant further agrees that he will not,
without the prior written consent of Company, remove or take from Company's or
any of its Affiliate's premises (or if previously removed or taken, he will, at
Company's request, promptly return) any written Proprietary Information or any
copies or extracts thereof. Upon the request and at the expense of Company,
Consultant shall promptly make all disclosures, execute all instruments and
papers and perform all acts reasonably necessary to vest and confirm in Company
and its Affiliates, fully and completely, all rights created or contemplated by
this Section 8.1. The term "Proprietary Information" shall not include
information that is or becomes generally available to the public other than as a
result of a disclosure by, or at the direction of, Consultant.

         8.2. Covenant Not to Compete; Nonsolicitation. (a) Consultant
recognizes, acknowledges and agrees with Company that, for so long as Consultant
renders the Services to Company and continuing for a period (the "Restricted
Period") equal to the greater of (i) one year following the termination of this
Agreement for any reason and (ii) the remainder of the Initial Term and any
Renewal Term, as the case may be, he will not, without the prior written consent
of Company, directly or indirectly, and whether as principal or investor or as
an employee, officer, director, manager, partner, consultant, agent or
otherwise, alone or in association with any other person, firm, company,
corporation or other business organization, carry on a Competing Business (as
hereinafter defined) in any country in which Company or any of its Affiliates
has engaged, presently engages, or will engage during such period, in a
Competing Business (including, without limitation, any area in which any
customer of Company or any of its Affiliates may be located).

                  (b) As a separate and independent covenant, Consultant agrees
with Company that, for so long as Consultant renders the Services to Company and
continuing for the Restricted Period, he will not in any way, directly or
indirectly (except in the course of her performance of the Services), for the
purpose of conducting or engaging in any Competing Business, call upon, solicit,
advise or otherwise do, or attempt to do, business with any person who is, or
was, during the then most recent 12-month period, a customer of Company or any
of its Affiliates, or take away or interfere or attempt to take away or
interfere with any custom, trade, business, patronage or affairs of Company or
any of its Affiliates, or interfere with or attempt to interfere with any person
who is, or was during the then most recent 12-month period, an employee,
officer, representative or agent of Company or any of its Affiliates, or
solicit, induce, hire or attempt to solicit, induce or hire any of them to leave
the employ of Company or any of its Affiliates or violate the terms of their
contracts, or any employment arrangements, with it.

                  (c) For purposes of this Section 8.2, carrying on a "Competing
Business" means operating a business that competes with the Business of the
Company or providing information pursuant thereto in a manner that competes with
Company or any of its Affiliates as of the date hereof or at any time thereafter
during the Restricted Period, and any business that, in the judgment of the
Board, competes with or is reasonably expected to compete with Company or any of
its Affiliates; provided, however, that nothing herein shall limit the right of
Consultant to own not more than 1% of any of the debt or equity securities of
any business organization that is then filing reports with the Securities and
Exchange Commission pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934.

            8.3. Exclusive Property. Consultant confirms that all Proprietary
Information is and shall remain the exclusive property of Company and its
Affiliates. All business records, papers and documents kept or made by
Consultant relating to the Business of Company shall be and remain the property
of Company and its Affiliates.

            8.4. Assignment of Inventions. (a) If at any time or times prior to,
during the term of this Agreement or during the two-year period following the
termination of this Agreement (either alone or with others) makes, conceives,
creates, discovers, invents or reduces to practice any invention, modification,
discovery, design, development, improvement, process, software program, work of
authorship, documentation, formula, data, technique, know-how, trade secret, or
intellectual property right whatsoever or any interest therein (whether or not
patentable or registrable under copyright, trademark or similar statutes or
subject to analogous protection (each, an "Invention") that (i) relates to the
Business of Company or any of its Affiliates or any customer of or supplier to
Company or any of its Affiliates or any of the products or services being
developed, manufactured or sold by Company or any of its Affiliates or which may
be used in relation therewith; or (ii) results from tasks assigned to Consultant
by Company or any of its Affiliates; or (iii) results from the use of premises
or personal property (whether tangible or intangible) owned, leased or
contracted for by Company or any of its Affiliates, then all such Inventions and
the benefits thereof are and shall immediately become the sole and absolute
property of Company and its assigns, as works made for hire or otherwise.

                                       5
<PAGE>

Consultant hereby agrees that he shall promptly disclose to Company (or any
persons designated by it) each such Invention. Consultant hereby assigns all
rights (including, but not limited to, rights to any inventions, patentable
subject matter, copyrights and trademarks) he may have or may acquire in the
Inventions and all benefits and/or rights resulting therefore to Company and its
assigns without further compensation and shall communicate, without cost or
delay, and without disclosing to others the same, all available information
relating thereto (with all necessary plans and models) to Company.

               (b) Consultant hereby agrees to, during the term of this
Agreement and at any time thereafter, at the request and cost of Company,
promptly sign, execute, make and do all such deeds, documents, acts and things
as Company and its duly authorized officers may reasonably require:

                   (i)    to apply for, obtain, register and vest in the name of
Company alone (unless the Company otherwise directs) patents,  copyrights,
trademarks or other analogous protection in any country throughout the world
relating to an Invention and when so obtained or vested to renew and restore the
same; and

                   (ii)   to defend any judicial, opposition or other
proceedings in respect of such applications and any judicial, opposition or
other proceedings, petitions or applications for revocation of any such patent,
copyright, trademark or other analogous protection.

               (c) If Company is unable, after reasonable effort, to secure
Consultant's signature on any application for patent, copyright, trademark or
other analogous registration or other documents regarding any legal protection
relating to an Invention, whether because of Consultant's physical or mental
incapacity or by any other reason whatsoever, Consultant hereby irrevocably
designates and appoints Company and its duly authorized officers and agents as
her agent and attorney-in-fact, to act for and in her behalf and stead to
execute and file any such application or applications or other documents and to
do all other lawfully permitted acts to further the prosecution and issuance of
patent, copyright or trademark registrations or any other legal protection
thereon with the same legal force and effect as if executed by Consultant.

         8.5.  Certain Remedies. Without intending to limit the remedies
available to Company and its Affiliates, Consultant agrees that a breach of any
of the covenants contained in this Section 8 may result in material and
irreparable injury to Company or its Affiliates for which there is no adequate
remedy at law, that it will not be possible to measure damages for such injuries
precisely and that, in the event of such a breach or threat thereof, Company and
its Affiliates shall be entitled to seek a temporary restraining order or a
preliminary or permanent injunction, or both, without bond or other security,
restraining Consultant from engaging in activities prohibited by this Section 8
or such other relief as may be required specifically to enforce any of the
covenants in this Section 8. Such injunctive relief in any court shall be
available to Company and its Affiliates in lieu of, or prior to or pending
determination in, any arbitration proceeding.

9.       Representations of Consultant. Consultant hereby represents and
warrants to Company that (i) he has the full, complete and entire right and
authority to enter into this Agreement, (ii) the execution of this Agreement by
Consultant and the performance of Consultant's Services hereunder will not
violate, or be a breach of, any agreement, law or commitment or responsibility
of any kind with a former employer, client, or any other person or entity
(whether government-owned or otherwise).

                                       6
<PAGE>

        Consultant has and will continue to truthfully disclose to Company the
following matters, whether occurring, at any time preceding the date of this
Agreement or at any time during the term of this Agreement:

         9.1.  any criminal complaint, indictment or criminal proceeding in
which Consultant is named as a defendant;

         9.2.  any allegation, investigation, or proceeding, whether
administrative, civil or criminal, against Employee by any licensing authority
or industry association; and

         9.3.  any allegation, investigation or proceeding, whether
administrative, civil, or criminal, against Consultant for violating
professional ethics or standards, or engaging in illegal, immoral or other
misconduct (of any nature or degree), relating to the Business of Company.

10.      Independent Contractor. Neither party is hereby constituted an
employee, agent or legal representative of the other party, except as expressly
set forth in this Agreement, and neither is granted any right or authority
hereunder to assume or create any obligation, expressed or implied, or to make
any representation, covenant, warranty or guaranty, except as expressly granted
or made in this Agreement. Nothing contained in this Agreement shall be
construed as to constitute Consultant or any of her employees, agents or
representatives as employees, agents or legal representatives of Company, it
being intended that the Consultant is an independent contractor of Calypso.

11.      Arbitration. Any controversy or claim arising out of or relating to
this Agreement, or the breach thereof, shall be settled by binding arbitration
in Miami-Dade County, Florida, USA, in accordance with the Commercial
Arbitration Rules of the American Arbitration Association, and judgment upon the
award rendered by the arbitrator may be entered in any court having jurisdiction
thereof. The arbitration shall be conducted in the English language before and
by a single arbitrator selected by the parties. If the parties have not selected
an arbitrator within ten (10) days of written demand for arbitration, the
arbitrator shall be selected by the American Arbitration Association pursuant to
the then current rules of that Association. The expenses of arbitration shall be
divided equally between the parties. The duty to arbitrate shall survive the
cancellation or termination of this Agreement.

12.      Termination; Effect of Termination.

         12.1  Termination. Either party may terminate this Agreement by written
notification to the other party pursuant to the terms and conditions contained
in the contract of employment dated January 12, 2005.

         12.2  Other Compensation or Benefits. Consultant shall have a further
right to receive other compensation and/or benefits pursuant to the terms and
conditions contained in the contract of employment dated January 12, 2005.

                                       7
<PAGE>

13.      Miscellaneous Provisions.

         13.1  This Agreement will be governed by and construed and enforced in
accordance with the laws of the State of Florida.

         13.2  This Agreement will be binding upon and will operate solely
for the benefit of the parties to this Agreement. This Agreement may not be
assigned by any party without the prior written consent of all of the parties
hereto, provided however, that notwithstanding the foregoing, Calypso shall be
entitled to assign this Agreement to its potential successor interest including
any non-U.S. entity without the consent of Consultant.

         13.3  This Agreement contains the entire agreement of the parties as to
the matters set forth herein. This Agreement cannot be altered, amended,
supplemented or modified except by an instrument in writing signed by all of the
parties to this Agreement.

         13.4  The invalidity or unenforceability of any particular provision of
this Agreement will not affect the other provisions of this Agreement, and the
Agreement will be construed in all respects as if such invalid or unenforceable
provisions were omitted.

         13.5  This Agreement may be executed in one or more counterparts, each
of which will be deemed an original and all of which together shall constitute
one agreement.

         13.6  This Agreement may be executed by facsimile signature and any
such signature shall be of the same force and effect as an original signature.

                                    * * * * *

         IN WITNESS WHEREOF, the parties hereto have executed this Consulting
Agreement as of the date set forth above.

                                    Bierman, Shohat, Loewy & Pizzi

                                    By:
                                       -----------------------------------------
                                       Michael A. Pizzi, Jr.
                                       Consultant

                                    CALYPSO WIRELESS, INC., a Delaware
                                    corporation.

                                    By:
                                       -----------------------------------------
                                       George Schilling, President & CEO

                                       8EXHIBIT 10.44

                          WALL STREET CONSULTANTS, INC.
                                32 E. 57th STREET
                              NEW YORK, N.Y. 10022

                        INVESTMENT BANKING (212) 888-4848
                         FOUNDED 1959 FAX (212) 888-4903

                               September 30, 2004

Mr. Richard Gabriel President & CEO DNAPrint genomics, Inc. 900 Cocoanut Avenue
Sarasota, FL 34236

Dear Mr. Gabriel:

This will confirm our understanding that The Wall Street Group, Inc. ("WSG") has
been retained as financial public relations counsel to DNAPrint genomics, Inc.
("DNAPrint"), beginning September 30, 2004 and continuing until cancelled as
hereinafter provided. As consideration for the services provided by WSG to
DNAPrint, as defined more specifically on Exhibit "A" attached, WSG will receive
a cash fee of $7,500 per month, payable in advance on the first day of each
month, plus reimbursement of reasonable and customary out-of-pocket expenses,
payable on receipt of an itemized statement detailing the incurred expenses. As
further consideration, DNAPrint grants WSG's affiliate, Wall Street
Consultant's, Inc. ("WSC") a five-year stock option, with piggyback registration
rights as more fully set forth below, on as many shares as could be purchased on
the open market for $100,000 at the closing bid price on September 24, 2004,
which option shall be evidenced by an option agreement in the form attached
hereto as Exhibit B. This contract may be cancelled by either party on ninety
(90) days written notice.

At the conclusion of 12 months, should this contract not be canceled by either
party on 90 days prior written notice, or modified, by mutual agreement, the
same terms will pertain to the next 12 month period, except that WSC will be
granted an additional five-year option on as many shares as could be bought for
$100,000 using as the exercise price, the closing bid price (or last sale price
if the common stock shall be listed on a national securities exchange) of the
common stock on the anniversary of the date of this Agreement. Each year
thereafter, this additional option grant and formula will be maintained, until
this agreement shall be canceled or modified, with each such option to be on the
terms and conditions of Exhibit A attached hereto.

DNAPrint agrees, with respect to all options granted under this contract that
for so long as such options remain exercisable and for a period of two years
thereafter, whenever DNAPrint proposes to file with the Securities and Exchange
Commission a registration statement (other than as to securities issued pursuant
to an employee benefit plan or as to a merger, acquisition or similar
transaction subject to Rule 145 promulgated under the Securities Act of 1933, as
amended), DNAPrint shall, at least 30 days prior to such filing, give written
notice of the proposed filing to WSC (or its successor or assigns, as the case
may be) setting forth the facts with respect to such proposed filing, and offer
to include in any such filing all of the shares subject to such options,
provided that DNAPrint receives a request at least 10 days prior to the proposed
filing date. All fees, disbursements and out-of-pocket expenses in connection
with the filing of any registration statement and in complying with applicable
securities and blue sky laws shall be borne by DNAPrint, all as more fully set
forth in the option agreement.

_____(DK) _____( )

                                       1
<PAGE>

This agreement can be canceled by either party on ninety (90) days written
notice. Should this agreement be canceled earlier than one year from the date
hereof as reflected below, WSC will return to DNAPrint a prorated portion of the
five-year stock option, which portion shall be based on the number of days
remaining in the twelve month retainer period. For this purpose (and all other
purposes of this agreement), the ninety (90) day period following notice of
termination shall be considered part of the retainer period.

It is understood that during the 90 day period following notice of termination,
DNAPrint will continue to honor its fee arrangement to WSG, including
reimbursement of reasonable expenses, and that WSG will continue to work on
behalf of DNAPrint.

In addition to introductions to brokers, analysts, money managers, funds and
institutions, WSG, will introduce DNAPrint to financing and investment banking
sources that can potentially assist in raising capital. If WSG is successful in
raising capital for DNAPrint through sources which have not previously been
introduced to DNAPrint or any of its officers, directors, employees or
consultants, it shall receive a 3.0% success fee of any additional funds raised.

Any disputes arising under or in connection with the interpretation of this
Agreement or the rights and obligations of the parties hereto shall be resolved
by arbitration in the City of New York under the rules of the American
Arbitration Association then obtaining. The decision of the arbitrator(s) shall
be final and binding, and judgment may be entered thereon in the Supreme Court
of the State of New York or in the United States District Court for the Southern
District of New York or any court having jurisdiction. The costs and expenses,
including counsel fees, shall be borne by each of the parties or as the
arbitrator(s) may determine at the request of any party.

As financial public relations counsel WSG must rely upon the accuracy and
completeness of the information supplied by DNAPrint and its officers and
directors. DNAPrint assumes full responsibility for the accuracy and
completeness of such information. DNAPrint agrees to indemnify WSG and pay WSG's
reasonable costs and expenses (including, without limitation, attorneys' fees
and costs) in any suit or proceeding arising out of any materially inaccurate
information provided by DNAPrint or any of its officers, directors, agents or
employees to WSG. Additionally, WSG agrees to issue no press releases on behalf
of DNAPrint which have not been cleared or reviewed by Mr. Richard Gabriel or
any other corporate officer he may designate.

If this agreement meets with your approval, please sign one copy and return it
to me, along with a check representing the first month's fee and the completed
Stock Option Agreement while retaining the other copy for your files.

_____(DK) _____( )

                                       2
<PAGE>

Very truly yours,

Donald Kirsch President

DK/jg

AGREED TO:

DNAPrint genomics, Inc.

By:
------------------------
Richard Gabriel
President & CEO

Dated:

_____(DK) _____( )

                                       3
<PAGE>

                                    Exhibit A

Utilizing only public information, WSG will introduce DNAPrint to a variety of
professional investor categories, including buy and sell side securities
analysts, money managers, high net worth brokers, investment letter news writers
and print, broadcast and internet journalists. WSG will also prepare and
disseminate press releases to news media and shareholders and assist the company
in the writing and editing of its shareholder messages. The effort will be
conducted in the key money markets of the United States and the objective is to
assist the company in creating a constituency which fully understands the
history of the company, its technology, its ambitions and its potential with
enough public information for these audiences to make their own decisions as to
whether or not the company merits continued attention.

_____(DK) _____( )

                                       4
<PAGE>

EXHIBIT B

                             DNAPrint genomics, Inc.

                             STOCK OPTION AGREEMENT

Option granted as of September 27, 2004 by DNAPrint genomics, Inc. (the
"Corporation") to Wall Street Consultants, Inc. (which together with its assigns
is sometimes hereinafter referred to as the "Grantee"):

1. The Option. In further consideration of the services to be provided to the
Corporation by the Grantee pursuant to that certain retainer agreement between
the Corporation and The Wall Street Group, Inc. dated September 27, 2004 (the
"Retainer Agreement"), the Corporation grants to the Grantee, effective on the
Date of Grant, a stock option (the "Option") to purchase, on the terms and
conditions herein set forth, up to the number of shares (the "Shares") of the
Corporation's fully paid, nonassessable shares of common stock, ("Common
Stock"), at the purchase price for the Shares set forth in Section 2 below, such
that the aggregate purchase price shall equal $100,000, but not less than 50,000
shares for the first year; provided, however, that in no event shall the
Corporation be required to sell a fractional Share, and the number of Shares
purchasable hereunder shall be limited accordingly.

2. The Purchase Price. The purchase price of the Shares shall be $
______________ per share (the "Option Price"), which price is the fair market
value of the Shares as of the Date of the Grant, as such Option Price shall be
adjusted from time to time pursuant to paragraph 10.

3. Exercise of Option.

(a) The Option is exercisable over a period ending five years from the Date of
Grant (the "Option Period"). The Option may be exercised from time to time
during the Option Period as to the total number of Shares subject to this Option
as determined under Section 1, or any lesser amount thereof, and the Option
shall continue as to any unexercised Shares.

(b) In the event the Grantee elects to exercise all or any portion of the
Option, the Grantee shall deliver to the Corporation written notice (the
"Notice") of such election, which Notice shall specify the number of Shares in
respect of which the Option is to be exercised, along with payment of the Option
Price of the Shares in respect of which the Option is exercised. The Option
Price shall be paid in full in United States dollars at the time of exercise;
provided, however, that if any fees are owed or expenses unreimbursed pursuant
to the Retainer Agreement, then the exercise price may be paid by the Grantee
agreeing to credit the corporation therefore. If the Option is exercised in
accordance with the provisions of this Agreement, the Corporation shall deliver
as soon as practicable to the Grantee a certificate or certificates representing
the number of Shares in respect of which the Option is being exercised, which
Shares shall be registered in the holder's name.

4. Sale of Shares. The Grantee shall not be entitled to sell, transfer, or
distribute the Shares except pursuant to (i) an effective registration statement
under the Securities Act of 1933, as amended (the "Act"), or (ii) if there be no
registration statement in effect, pursuant to an exemption from registration
under the Act. Prior to offering or selling the Shares upon claim of exemption,
the holder shall obtain a written opinion from counsel reasonably satisfactory
to the Corporation to the effect that such exemption is available or shall
deliver a "no-action" letter from the Securities and Exchange Commission with
respect to the proposed sale, transfer or distribution of the Shares.

_____(DK) _____( )

                                       5
<PAGE>

5. Registration Rights. The Corporation agrees that, for so long as the Option
remains exercisable and for a period of two years thereafter, whenever the
Corporation proposes to file with the Securities and Exchange Commission a
registration statement (other than as to securities issued pursuant to an
employee benefit plan or as to a merger, acquisition or similar transaction
subject to Rule 145 promulgated under the Securities Act), the Corporation
shall, at least 30 days prior to such filing, give written notice of such
proposed filing to the Grantee setting forth the facts with respect to such
proposed filing, and shall offer to include in any such filing the Shares
subject to the Option provided that the Corporation receives a request therefor
at least 10 days prior to the proposed filing date. All fees, disbursements and
out-of-pocket expenses in connection with the filing of any registration
statement and in complying with applicable securities and blue sky laws shall be
borne by the Corporation.

The Corporation will indemnify and hold harmless the Grantee and each person who
controls the Grantee within the meaning of Section 15 of the Act or Section 20
of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), from
and against any and all losses, claims, damages, expenses and liabilities, joint
or several (including any investigation, legal and other expenses incurred in
connection with, and any amount paid in any settlement effected with the
Corporation's consent (not to be unreasonably withheld) of, any action, suit or
proceeding or any claim asserted), to which they, or any of them, may become
subject under the Act, the Exchange Act or other federal or state law or
regulation, at common law or otherwise, insofar as such losses, claims, damages
or liabilities arise out of or are based on (A) any untrue statement or alleged
untrue statement of a material fact contained in the registration statement
filed with respect to the Shares (including any related preliminary or
definitive prospectus, or any amendment or supplement to such registration
statement or prospectus), (B) any omission or alleged omission to state in such
document a material fact required to be stated in it or necessary to make the
statements in it not misleading, or (C) any violation by the Corporation of the
Act, the Exchange Act, any blue sky laws or any rule or regulation thereunder in
connection with such registration; provided however, that the Corporation will
not be liable to the extent that such loss, claim, damage, expense or liability
arises from and is based solely on a material untrue statement or omission or
alleged material untrue statement or omission made in such registration
statement and in conformity with information furnished in writing to the
Corporation by the Grantee expressly for use in such registration statement.
With respect to the matter referred to in the proviso of the foregoing sentence,
the Grantee will indemnify and hold harmless the Corporation from and against
any and all losses, claims, damages, expenses and liabilities, joint or several,
to which it may become subject under the Act, the Exchange Act or other federal
or state statutory law or regulation, at common law or otherwise to the same
extent provided in the immediately preceding sentence.

Promptly after receipt by an indemnified party of notice of the commencement of
any action involving matters referred to in the foregoing paragraph, such
indemnified party will, if a claim in respect thereof is to be made against any
indemnifying party, thereof and the indemnifying party shall have the right to
participate in, and, to the extent the indemnifying party so desires, jointly
with any other indemnifying party similarly notified, to assume the defense
thereof at its own expense with counsel reasonably satisfactory to the
indemnified party or parties, and in such case, if the indemnified party desires
to retain its own counsel, the expense of such counsel shall be borne by the
indemnified party.

_____(DK) _____( )

                                       6
<PAGE>

6. Termination of Retainer Agreement. In the event the engagement of the Wall
Street Group, Inc. under the Retainer Agreement ceases by reason of the
termination of the Retainer Agreement by either party on ninety (90) days notice
pursuant to the provisions thereof, the maximum number of Shares exercisable
hereunder shall be multiplied by a fraction, the numerator of which shall be the
number of days which shall have expired from the Date of Grant to the earlier of
the next subsequent anniversary date of the Retainer Agreement or ninety (90)
days after receipt by the Wall Street Group, Inc. of the notice of termination
sent pursuant thereto, and the denominator of which shall be 365, and such
product shall thereupon be the maximum number of Shares purchasable hereunder;
provided, however, that in no event shall the Corporation be required to sell a
fractional Share, and the number of Shares purchasable hereunder shall be
limited accordingly.

7. Successors and Assigns. This agreement shall be binding upon and shall inure
to the benefit of the parties' respective successors and assigns.

8. Expiration of Option. This Option is not exercisable after the expiration of
five years from the Date of Grant.

9. Rights.

(a) The granting of this Option shall not confer upon the Grantee any right to
continue to be retained by the Corporation or any of its subsidiaries, subject,
however, to the terms of the Retainer Agreement between the Grantee and the
Corporation.

(b) The Grantee shall not, by reason of the granting to it of the Option, have
or thereby acquire any rights of a stockholder of the Corporation with respect
to any Shares unless and until it has tendered full payment of the Option Price
for such Shares.

10. Adjustment of Number of Shares and Option Price. In the event that a
dividend shall be declared upon the Shares payable in shares of Common Stock,
the number of Shares then subject to the Option and the Option Price shall be
adjusted by adding to each of such Shares the number of shares of Common Stock
which would be distributable thereon if such Share had been outstanding on the
date fixed for determining the stockholders entitled to receive such stock
dividend and reducing the Option Price proportionally. In the event that the
outstanding Shares shall be changed into or exchanged for a different number or
kind of shares of stock or other securities of the Corporation or of another
corporation, whether through reorganization, recapitalization, stock split-up,
combination of shares, merger or consolidation, then there shall be substituted
for each Share subject to the Option the number and kind of shares of stock or
other securities into which each outstanding share of Common Stock shall be so
changed or for which each such share shall be exchanged; provided, however, that
in the event that such change or exchange results from a merger or
consolidation, and in the judgment of the Board of Directors of the Corporation
such substitution cannot be effected or would be inappropriate, or if the
Corporation shall sell all or substantially all of its assets, the Corporation
shall use reasonable efforts to effect some other adjustment of the Option which
the Board of Directors, in its sole discretion, shall deem equitable. In the
event that there shall be any change, other than as specified above in this
Paragraph 10, in the number or kind of outstanding Shares or of any stock or
other securities into which such Shares shall have been changed or for which
they shall have been exchanged, then, if the Board of Directors shall determine
that such change equitably requires an adjustment in the number or kind of
Shares then subject to the Option, such adjustment shall be made by the Board of
Directors and shall be effective and binding for all purposes of this Option. In
the case of any such substitution or adjustment as provided for in this
paragraph, the Option Price will be the option price for all shares of stock or
other securities which shall have been substituted for each Share or to which
such Share shall have been adjusted pursuant to this paragraph 10. No adjustment
or substitution provided for in this paragraph 10 shall require the Corporation
to sell a fractional Share, and the total substitution or adjustment shall be
limited accordingly.

_____(DK) _____( )

                                       7
<PAGE>

11. Reserve of Shares. The Corporation will reserve and set about and have at
all times, free from preemptive rights, a number of shares or authorized but
unissued Common Stock deliverable upon exercise of the Option, and it will have
at all times any other rights or privileges provided for therein sufficient to
enable it at any time to fulfill all of its obligations in this Agreement.

12. Governing Law. This Agreement shall be governed by, and construed and
enforced in accordance with, the laws of the State of New York.

If the foregoing is in accordance with the Grantee's understanding and approved
by it, it may so confirm by signing and returning the duplicate of this
Agreement delivered for that purpose.

DNAPrint genomics, Inc.

Dated:__________ By:_________________________

The foregoing is in accordance with the undersigned's understanding and is
hereby confirmed and agreed to as of the Date of Grant.

                          WALL STREET CONSULTANTS, INC.

Dated:__________ By:_______________________

                                       8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00079-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00079-of-00352.parquet"}]]